⌘K

Home/Filings/4/0001209191-23-049751

4//SEC Filing

Alland Leila 4

Accession 0001209191-23-049751

CIK 0001699382other

View on SEC.gov Company Profile

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 4:22 PM ET

Size

4.8 KB

Accession

0001209191-23-049751

Insider Transaction Report

Form 4

Period: 2023-09-15

PMV Pharmaceuticals, Inc.PMVP

Chief Medical Officer

Transactions

Sale
Common Stock
2023-09-15$6.62/sh−6,291$41,646→ 45,909 total

Footnotes (1)

[F1]The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

PMV Pharmaceuticals, Inc.

CIK 0001699382

Entity typeother

Related Parties

1

filerCIK 0001825216

Filing Metadata

Form type: 4
Filed: Sep 17, 8:00 PM ET
Accepted: Sep 18, 4:22 PM ET
Size: 4.8 KB

View on SEC.gov